{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:52:56Z","timestamp":1789015976311,"version":"build-2803163510"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":75,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-20216"],"award-info":[{"award-number":["IG-20216"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"University of Padua","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.blre.2023.101058","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T12:26:06Z","timestamp":1676895966000},"page":"101058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Not all LGL leukemias are created equal"],"prefix":"10.1016","volume":"60","author":[{"given":"Gianpietro","family":"Semenzato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Calabretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Baril\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Rebecca","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Teramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Zambello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2023.101058_bb0005","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(75)92127-3","article-title":"Chronic lymphocytic leukemia of T-cell origin: Immunological and clinical evaluation in eleven patients","volume":"ii","author":"Brouet","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2023.101058_bb0010","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9343(77)90422-3","article-title":"Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics","volume":"62","author":"McKenna","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2023.101058_bb0015","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood.V59.4.688.688","article-title":"Immunologic evaluation of T chronic lymphocyte leukemia cells: correlations among phenotype, functional activities, and morphology","volume":"59","author":"Pandolfi","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood.V68.5.1142.1142","article-title":"Heterogeneity of large granular lymphocyte proliferations: delineation of two major subsets","volume":"68","author":"Chan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0025","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V63.6.1271.1271","article-title":"Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process?","volume":"63","author":"Semenzato","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V66.2.259.259","article-title":"Granulated T cell lymphocytosis with neutropenia: malignant or benign chronic lymphoproliferative disorders?","volume":"66","author":"McKenna","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00321070","article-title":"Abnormal expansion of granular lymphocytes: Reactive lymphocytosis or chronic leukemia? Case report and literature review","volume":"52","author":"Gastl","year":"1986","journal-title":"Blut"},{"key":"10.1016\/j.blre.2023.101058_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0167-5699(99)01472-3","article-title":"T-cell clonality in immune responses","volume":"20","author":"Maini","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.blre.2023.101058_bb0045","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1084\/jem.162.6.2156","article-title":"T cell receptor beta chain gene rearrangements on lymphoproliferative disorders of granular lymphocytes\/natural killer cells","volume":"162","author":"Rambaldi","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2023.101058_bb0050","first-page":"247","article-title":"Analysis of T-cell receptor beta chain (T beta) gene rearrangements demonstrates the monoclonal nature of T-cell chronic lymphoproliferative disorders","volume":"67","author":"Fo\u00e0","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2023.101058_bb0060","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/1097-0142(19871215)60:12<2971::AID-CNCR2820601220>3.0.CO;2-O","article-title":"The lymphoproliferative disease of granular lymphocytes. A heterogeneous disease ranging from indolent to aggressive conditions","volume":"60","author":"Semenzato","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2023.101058_bb0065","first-page":"617","article-title":"Granular lymphocyte lymphoproliferative disorders: report of 12 cases and review of the literature","volume":"2","author":"Oshimi","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0070","first-page":"4806","article-title":"Clonal analysis using recombinant DNA probes from X-chromosome","volume":"47","author":"Vogelstein","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2023.101058_bb0075","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.V81.9.2363.2363","article-title":"Clonal studies of CD3-negative lymphoproliferative disease of granular lymphocytes","volume":"81","author":"Nash","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0080","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2002-12-3898","article-title":"Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes","volume":"102","author":"Zambello","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0085","doi-asserted-by":"crossref","first-page":"42938","DOI":"10.18632\/oncotarget.5480","article-title":"Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality","volume":"6","author":"Barcena","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.blre.2023.101058_bb0090","doi-asserted-by":"crossref","first-page":"821382","DOI":"10.3389\/fonc.2022.821382","article-title":"Toward a better classification system for NK-LGL disorders","volume":"12","author":"Drillet","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2023.101058_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0100","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.blre.2023.101058_bb0105","series-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues, ed 4","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.blre.2023.101058_bb0110","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0115","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdu369","article-title":"Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients","volume":"25","author":"Poullot","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.blre.2023.101058_bb0120","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1038\/bcj.2016.59","article-title":"A population-based study of large granular lymphocyte leukemia","volume":"6","author":"Shah","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2023.101058_bb0125","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2023.101058_bb0130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0135","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1349-7006.2012.02251.x","article-title":"Aggressive natural killer cell leukemia: Therapeutic potential of L-aparaginase and allogenic hematopoietic stem cell transplantation","volume":"103","author":"Ishida","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.blre.2023.101058_bb0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.leukres.2006.06.020","article-title":"T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells","volume":"31","author":"Baesso","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2023.101058_bb0145","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0150","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)63032-5","article-title":"Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)\/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease","volume":"159","author":"Lima","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0155","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1182\/blood-2006-05-022277","article-title":"Monoclonal TCR-Vbeta13.1+\/CD4+\/NKa+\/CD8-\/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin","volume":"109","author":"Garrido","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0160","first-page":"6140","article-title":"Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: Superantigens activation of clonal CD3+ granular lymphocytes","volume":"55","author":"Zambello","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2023.101058_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V98.1.165","article-title":"Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1309\/3A32DTVMH640M2QA","article-title":"Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: A comparison with conventional T-cell immunophenotyping and molecular genetic techniques","volume":"121","author":"Morice","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cyto.b.21782","article-title":"Single antibody detection of T-cell receptor ab clonality by flow cytometry rapidly identifies mature T-cell neoplasms and monotypic small CD8-positive subsets of uncertain significance","volume":"98B","author":"Shi","year":"2020","journal-title":"Cytom Part B"},{"key":"10.1016\/j.blre.2023.101058_bb0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/cancers14020408","article-title":"High-sensitive TRBC1-based flow cytometric assessment of T-cell clonality in T\u03b1\u03b2-large granular lymphocytic leukemia","volume":"14","author":"Mu\u00f1oz-Garc\u00eca","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.blre.2023.101058_bb0185","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood.V84.7.2315.2315","article-title":"CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia","volume":"84","author":"Gentile","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0190","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocyte leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2007.04.011","article-title":"Clinical spectrum of gammadelta T cell LGL leukemia: analysis of 120 cases","volume":"32","author":"Bourgault-Rouxel","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2023.101058_bb0200","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","article-title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","volume":"34","author":"Baril\u00e0","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0205","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nri3904","article-title":"\u03b3\u03b4 T cells in cancer","volume":"15","author":"Silva-Santos","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.blre.2023.101058_bb0210","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1038\/s41467-022-31015-x","article-title":"Combined immunophenotypic and molecular evaluation contributes to better define TCR\u03b3\u03b4 lymphoproliferative disorders","volume":"13","author":"Teramo","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2023.101058_bb0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for the diagnosis","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0220","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.171.3.695","article-title":"A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells","volume":"171","author":"Moretta","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2023.101058_bb0225","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.172.6.1589","article-title":"Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition","volume":"172","author":"Moretta","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2023.101058_bb0230","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V81.9.2381.2381","article-title":"Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes","volume":"81","author":"Zambello","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0235","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2003-02-0400","article-title":"Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes","volume":"103","author":"Epling-Burnette","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0240","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/blood-2002-08-2408","article-title":"Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C\/E and NKD2D killer cell receptors","volume":"101","author":"Bigouret","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0245","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/leu.2009.304","article-title":"Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets","volume":"24","author":"Morice","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41408-018-0088-1","article-title":"Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation","volume":"8","author":"Baril\u00e0","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2023.101058_bb0255","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41588-022-01059-2","article-title":"CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk","volume":"54","author":"Baer","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2023.101058_bb0260","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood.2020006721","article-title":"Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells","volume":"137","author":"Pastoret","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0265","doi-asserted-by":"crossref","first-page":"e0158827","DOI":"10.1371\/journal.pone.0158827","article-title":"Flow cytometric immunophenotyping is sensitive for the early diagnosis of de novo aggressive natural killer cell leukemia (ANKL): A multicenter retrospective analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2023.101058_bb0270","doi-asserted-by":"crossref","first-page":"918487","DOI":"10.3389\/fimmu.2022.918487","article-title":"Comprehensive analysis and summary of the value of immunophenotypes of mature NK cell tumors for differential diagnosis, treatment, and prognosis","volume":"13","author":"Pu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2023.101058_bb0275","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"De Leval","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0280","doi-asserted-by":"crossref","first-page":"61876","DOI":"10.18632\/oncotarget.18711","article-title":"STAT3 mutation impacts biological and clinical features of T-LGL leukemia","volume":"8","author":"Teramo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.blre.2023.101058_bb0285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2017.12.014","article-title":"STAT3 mutations and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia","volume":"73","author":"Shi","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0290","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.3390\/cancers12123508","article-title":"STAT3 and STAT5B mutations in T\/NK-chronic lymphoproliferative disorders of large granular lymphocytes (LGL): association with disease features","volume":"12","author":"Mu\u00f1oz-Garc\u00eca","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.blre.2023.101058_bb0295","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood.2021015301","article-title":"Interrogating molecular genetics to refine LGLL classification","volume":"139","author":"Semenzato","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0300","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0305","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2023.101058_bb0310","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","article-title":"High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia","volume":"128","author":"Andersson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-022-00630-8","article-title":"Identification of novel STAT5B mutations and characterization of TCR\u03b2 signatures in CD4+ T large granular lymphocyte leukemia","volume":"12","author":"Bhattacharya","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2023.101058_bb0320","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/leu.2012.350","article-title":"STAT3 mutations are highly specific for large granular lymphocytic leukemia","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0325","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.3390\/cancers13153900","article-title":"Clinicobiological characteristics and outcomes of patients with T-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of natural killer cells from a single institution","volume":"13","author":"Riviero","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.blre.2023.101058_bb0330","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jmoldx.2014.02.005","article-title":"Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia","volume":"16","author":"Kristensen","year":"2014","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.blre.2023.101058_bb0335","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ejh.13038","article-title":"Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools","volume":"100","author":"Kurt","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/bloodadvances.2018027862","article-title":"Subclonal STAT3 mutations solidify clonal dominance","volume":"3","author":"Kerr","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2023.101058_bb0345","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/cyto.b.22034","article-title":"CD4+ T-cell large granular lymphocytic leukemia with STAT3 mutation and neutropenia","volume":"102","author":"Hafeez","year":"2022","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.blre.2023.101058_bb0350","article-title":"T\u03b3\u03b4 large granular lymphocyte leukemia identifies a subset of patients with more symptomatic disease: analysis of a large international cohort of 127 patients","author":"Baril\u00e0","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0355","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12185-019-02625-x","article-title":"STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells","volume":"109","author":"Kawakami","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41408-020-0309-2","article-title":"A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells","volume":"10","author":"Gasparini","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2023.101058_bb0365","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood.2020005831","article-title":"Frequent somatic TET2 mutations in Chronic NK-LGL Leukemia with distinct patterns of cytopenias","volume":"138","author":"Olson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0370","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.2021013164","article-title":"Genomic and transcriptomic sequencing reveals the landscape of large granular lymphocyte leukemia","volume":"139","author":"Cheon","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0375","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2023.101058_bb0380","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell Leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.blre.2023.101058_bb0385","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0000000000001518","article-title":"Genomic and immunophenotypic landscape of aggressive NK-cell leukemia","volume":"44","author":"El Hussein","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0390","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/leu.2015.263","article-title":"Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia","volume":"30","author":"Andersson","year":"2016","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2023.101058_bb0395","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V67.2.516.516","article-title":"Abnormalities of chromosome 7q and Tac expression in T cell leukemias","volume":"67","author":"Brito-Babapulle","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0400","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.blre.2023.101058_bb0405","doi-asserted-by":"crossref","first-page":"613570","DOI":"10.3389\/fonc.2020.613570","article-title":"Lack of viral load within chronic lymphoproliferative disorder of natural killer cells: What is outside the leukemic clone?","volume":"10","author":"Giussani","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2023.101058_bb0410","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2014.00072","article-title":"Activating KIRs in Chronic lymphoproliferative disorder of NK Cells: Protection from viruses and disease induction?","volume":"5","author":"Zambello","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2023.101058_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/aid.2009.0124","article-title":"LGL leukemia and HTLV","volume":"26","author":"Thomas","year":"2010","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.blre.2023.101058_bb0420","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2141.1998.00691.x","article-title":"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia","volume":"101","author":"Loughran","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0425","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/bjh.16223","article-title":"Retroviral sero-reactivity in LGL leukaemia patients and family members","volume":"188","author":"Nyland","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1742-4690-5-86","article-title":"Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules","volume":"5","author":"Teruya","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.blre.2023.101058_bb0435","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2141.2000.01934.x","article-title":"Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice","volume":"108","author":"Lamy","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0440","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1182\/blood-2008-02-136382","article-title":"Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling","volume":"112","author":"Epling-Burnette","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0445","first-page":"88","article-title":"Retrovirus insertion site analysis of LGL leukemia patient genomes","volume":"12","author":"Li","year":"2019","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.blre.2023.101058_bb0450","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1182\/blood-2005-05-1972","article-title":"Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL)","volume":"106","author":"Zambello","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0455","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.exphem.2009.06.010","article-title":"Analysis of NK cell\/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30","volume":"37","author":"Balsamo","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0460","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2141.2002.03646.x","article-title":"DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes","volume":"118","author":"Makishima","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0465","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/sj.leu.2403261","article-title":"DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions","volume":"18","author":"Choi","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0470","first-page":"529","article-title":"Constitutive production of proinflammatory cytokines RANTES, MIP-1\u03b2 and IL-18 characterizes LGL leukemia","volume":"26","author":"Kothapalli","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.blre.2023.101058_bb0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1532\/IJH97.07002","article-title":"Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG","volume":"86","author":"Momose","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0480","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1182\/blood-2012-07-441378","article-title":"Intrinsic and extrinsic mechanisms contribute to maintain the JAK\/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia","volume":"121","author":"Teramo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0485","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/bcmd.2001.0379","article-title":"Fatal leukemia in interleukin-15 transgenic mice","volume":"27","author":"Fehniger","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2023.101058_bb0490","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V89.1.201","article-title":"Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes","volume":"89","author":"Zambello","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0495","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/0008-5472.CAN-08-3735","article-title":"Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias","volume":"69","author":"Hodge","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2023.101058_bb0500","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ccr.2012.09.009","article-title":"Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation","volume":"22","author":"Mishra","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.blre.2023.101058_bb0505","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1073\/pnas.0806447105","article-title":"Network model of survival signaling in large granular lymphocyte leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2023.101058_bb0510","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2009-06-223719","article-title":"Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway","volume":"115","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0515","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-022-29173-z","article-title":"Single-cell transcriptomics identifies synergistic role of leukemic and non-leukemic immune repertories in CD8+ T cell large granular lymphocytic leukemia","volume":"13","author":"Huuhtanen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2023.101058_bb0520","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","article-title":"Dysregulation of CD95\/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia","volume":"92","author":"Lamy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0525","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","article-title":"Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0530","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0535","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2141.2000.01934.x","article-title":"Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice","volume":"108","author":"Lamy","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0540","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3324\/haematol.2019.225060","article-title":"Identification of a miR-146b-FasL axis in the development of neutropenia in T-Large Granular Lymphocyte Leukemia","volume":"105","author":"Mariotti","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2023.101058_bb0545","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/s41375-021-01296-0","article-title":"STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation","volume":"35","author":"Kim","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0550","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4161\/cc.5.22.3449","article-title":"Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes","volume":"5","author":"Schade","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.blre.2023.101058_bb0555","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1038\/sj.onc.1208122","article-title":"ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)","volume":"23","author":"Epling-Burnette","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2023.101058_bb0560","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1080\/15384047.2015.1078949","article-title":"Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia","volume":"16","author":"LeBlanc","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.blre.2023.101058_bb0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-4781(02)00529-8","article-title":"Characterization of a human sphingosine-1-phosphate receptor gene (S1P5) and its differential expression in LGL leukemia","volume":"1579","author":"Kothapalli","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2023.101058_bb0570","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/s41375-022-01695-x","article-title":"All that glitters is not LGL leukemias","volume":"36","author":"Semenzato","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0575","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41467-022-29175-x","article-title":"Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells","volume":"13","author":"Gao","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2023.101058_bb0580","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41375-021-01231-3","article-title":"Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia","volume":"35","author":"Lundgren","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0585","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41408-022-00632-6","article-title":"Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)","volume":"12","author":"Salama","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2023.101058_bb0590","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41375-022-01592-3","article-title":"An Italian multi-center experience of hypocellular Myelodysplastic Syndromes (h-MDS): from clinical description to immunological characterization","volume":"36","author":"Calabretto","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0595","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41375-019-0601-y","article-title":"Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome","volume":"34","author":"Durrani","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0600","first-page":"1616","article-title":"Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center","volume":"11","author":"Ai","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.blre.2023.101058_bb0605","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.2147\/OTT.S222378","article-title":"Pathophysiologic mechanisms and management of large granular lymphocytic leukemia associated pure red cell aplasia","volume":"12","author":"Qiu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.blre.2023.101058_bb0610","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ajh.20374","article-title":"Clonal T cells of pure red-cell aplasia","volume":"79","author":"Masuda","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0615","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/bloodadvances.2018022723","article-title":"Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia","volume":"2","author":"Kawakami","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2023.101058_bb0620","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s12185-022-03310-2","article-title":"T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia","volume":"115","author":"Kawakami","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0625","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1038\/ncomms15869","article-title":"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis","volume":"8","author":"Savola","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2023.101058_bb0630","doi-asserted-by":"crossref","first-page":"854499","DOI":"10.3389\/fonc.2022.854499","article-title":"Pathogenesis and treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the setting of rheumatic disease","volume":"12","author":"Couette","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2023.101058_bb0635","doi-asserted-by":"crossref","first-page":"1000265","DOI":"10.3389\/fmed.2022.1000265","article-title":"STAT3 mutations in \u201cgray zone\u201d cases of T-cell large granular lymphocyte leukemia associated with autoimmune rheumatic diseases","volume":"9","author":"Gorodetskiy","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.blre.2023.101058_bb0640","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/10428190801932635","article-title":"Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia","volume":"49","author":"Viny","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2023.101058_bb0645","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2008-03-146241","article-title":"Expanded cells in monoclonal TCR-alphabeta+\/ CD4+\/NKa+\/CD8-\/+dim T-LGL lymphocytosis recognize hCMV antigens","volume":"112","author":"Rodr\u00edguez-Caballero","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0650","first-page":"1207","article-title":"Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative NK-type lymphoproliferative disease of granular lymphocytes","volume":"9","author":"Zambello","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0655","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.leukres.2016.04.001","article-title":"Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations","volume":"45","author":"Tanahashi","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2023.101058_bb0660","doi-asserted-by":"crossref","first-page":"61419","DOI":"10.18632\/oncotarget.11360","article-title":"Methotrexate therapy of T-cell large granular leukemia impact of STAT3 mutation","volume":"7","author":"Qiu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.blre.2023.101058_bb0665","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/cells10102800","article-title":"Neutropenia and Large Granular Lymphocyte Leukemia: from pathogenesis to therapeutic options","volume":"10","author":"Calabretto","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.blre.2023.101058_bb0670","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.immuni.2022.11.001","article-title":"STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+T cell dysregulation and accumulation","volume":"55","author":"Masle-Farquhar","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.blre.2023.101058_bb0675","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0000000000000634","article-title":"Clinicopathologic characterization of aggressive natural killer cell leukemia involving different tissue sites","volume":"40","author":"Gao","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0680","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41379-020-0568-2","article-title":"T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics","volume":"33","author":"Shi","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0685","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.3390\/cancers14215236","article-title":"LGL clonal expansion and unexplained cytopenia: two clues don\u2019t make an evidence","volume":"14","author":"Calabretto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.blre.2023.101058_bb0690","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/ajcp\/aqy173","article-title":"Utility of a simple and robust flow cytometry assay for rapid clonality testing in mature peripheral T-cell lymphomas","volume":"151","author":"Novikov","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0695","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3324\/haematol.2020.270504","article-title":"The time has come for next-generation sequencing in routine diagnostic workup in hematology","volume":"106","author":"Haferlach","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2023.101058_bb0700","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V99.1.268","article-title":"Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B","volume":"99","author":"Morice","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0705","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2006.01.003","article-title":"Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome","volume":"20","author":"Burks","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2023.101058_bb0710","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1309\/AJCPJ57YTEGLIUOI","article-title":"Spectrum of clonal large granular lymphocytes (LGLs) of \u03b1\u03b2 T Cells: T-cell clones of undetermined significance, T-cell LGL leukemias, and T-cell immunoclones","volume":"144","author":"Singleton","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0715","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hon.917","article-title":"The root of many evils: indolent large granular lymphocyte leukemia and associated disorders","volume":"28","author":"Zang","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.blre.2023.101058_bb0720","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/ijlh.13949","article-title":"T-cell clonality testing for the diagnosis of T-cell large granular lymphocytic leukemia: Are we identifying pathology or incidental clones\u202f?","volume":"44","author":"Chin-Yee","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0725","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beha.2019.06.006","article-title":"T cell large granular lymphocyte leukemia and chronic NK lymphocytosis","volume":"32","author":"Baril\u00e0","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0730","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Nieto Y prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.blre.2023.101058_bb0735","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","volume":"136","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0740","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T cell lymphoma","volume":"7","author":"McKInney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.blre.2023.101058_bb0745","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0750","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V84.7.2164.2164","article-title":"Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate","volume":"84","author":"Loughran","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0755","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","article-title":"Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report of 229 cases","volume":"95","author":"Bareau","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2023.101058_bb0760","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/10428194.2017.1339880","article-title":"Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)","volume":"59","author":"Sanikommu","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2023.101058_bb0765","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/leu.2013.359","article-title":"Cyclophosphamide as a first-line therapy in LGL leukemia","volume":"28","author":"Moignet","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0770","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/leu.2014.298","article-title":"Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)","volume":"29","author":"Loughran","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0775","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fped.2018.00292","article-title":"Aggressive NK-cell leukemia","volume":"6","author":"Ishida","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.blre.2023.101058_bb0780","first-page":"139","article-title":"Improving prognosis of aggressive natural killer cell leukemia in Japan","author":"Fujimoto","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0785","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(15)00227-6","article-title":"Alemtuzumab in T-cell large granular lymphocytic leukemia: interim results from a single-arm, open-label, phase 2 study","volume":"3","author":"Dimitriu","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0790","first-page":"139","article-title":"Intense immunosuppressive therapy (anti-thymocyte globulin, alemtuzumab) as salvage therapy in refractory T-cell large granular lymphocytic leukemia and pure red cell aplasia","author":"Uliah","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0795","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2004.04852.x","article-title":"Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients","volume":"124","author":"Ma","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101058_bb0800","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.22032","article-title":"T-cell large granular lymphocytic leukemia. A report on the treatment of 29 patients and a review of the literature","volume":"107","author":"Osuji","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2023.101058_bb0805","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00277-013-1746-9","article-title":"Bendamustine salvage therapy for T cell neoplasms","volume":"92","author":"Zaja","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0810","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2013-03-491464","article-title":"Long-term remission of T-cell large granular lymphocytic leukemia associated with rheumatoid arthritis after rituximab therapy","volume":"122","author":"Cornec","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0815","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.exphem.2008.04.005","article-title":"Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia","volume":"36","author":"Subbiah","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0820","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/leu.2015.256","article-title":"Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation","volume":"30","author":"Marchand","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0825","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.20853","article-title":"Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature","volume":"82","author":"Alekshun","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0830","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00277-003-0801-3","article-title":"Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis","volume":"83","author":"La Nasa","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0835","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/leu.2015.280","article-title":"Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia","volume":"29","author":"Bilori","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0840","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1002\/ajh.26275","article-title":"Ruxolitinib for refractory large granular lymphocyte leukemia","volume":"96","author":"Moignet","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2023.101058_bb0845","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2012-08-450585","article-title":"Phase 1 trial of IL-15 trans presentation blockade using humanized Mik\u03b21 mAb in patients with T-cell large granular lymphocytic leukemia","volume":"121","author":"Waldmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0850","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41375-018-0290-y","article-title":"IL-2 and IL-15 blockade by BNZ-1, an inhibitory of selective \u03b3-chain cytokines, decreases leukemic T-cell viability","volume":"33","author":"Wang","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0855","first-page":"134","article-title":"Blockade of IL-15 utilizing BNZ-1, a selective g-chain inhibiting peptide, is safe and has clinical activity in patients with T-cell large granular lymphocytic leukemia (T-LGLL): results of a phase I\/II multi-center clinical trial","author":"Brammer","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101058_bb0860","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41375-021-01480-2","article-title":"miR-181a is a novel player in the STAT3-mediated survival network of TCR\u03b1\u03b2+ CD8+ T large granular lymphocyte leukemia","volume":"36","author":"Assmann","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2023.101058_bb0865","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3324\/haematol.2010.023358","article-title":"Lack of expression of inhibitory KIR3DL1 receptor in patients with NK-type lymphoproliferative disease of granular lymphocytes","volume":"95","author":"Gattazzo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2023.101058_bb0870","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13148-022-01362-z","article-title":"Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker","volume":"14","author":"Johansson","year":"2022","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.blre.2023.101058_bb0875","first-page":"e573","article-title":"Hijacking the pathway: perspectives in the treatment of mature T-cell leukemias","volume":"5","author":"Wahnschaffe","year":"2021","journal-title":"HemaSfere"},{"key":"10.1016\/j.blre.2023.101058_bb0880","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra2101920","article-title":"Somatic mutations in \u201cbenign\u201d disease","volume":"384","author":"Mustjoki","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2300019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2300019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:29:25Z","timestamp":1759436965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X2300019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":176,"alternative-id":["S0268960X2300019X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2023.101058","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Not all LGL leukemias are created equal","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2023.101058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101058"}}